Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 5/2018

23.02.2017 | Reviews

Crystal arthritides – gout and calcium pyrophosphate arthritis

Part 2: clinical features, diagnosis and differential diagnostics

verfasst von: Dr. med. S. Schlee, L. C. Bollheimer, T. Bertsch, C. C. Sieber, P. Härle

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Gout develops in four stages beginning with an asymptomatic increase in blood levels of uric acid. An acute gout attack is an expression of an underlying inflammatory process, which in the course of time is self-limiting. Without therapy monosodium urate crystals remain in the synovial fluid and synovial membrane and trigger more acute attacks. In the course of the disease monosodium urate crystals form deposits (tophi) leading in severe forms to irreversible joint deformities with loss of functionality. In 20% of cases gout leads to involvement of the kidneys. Overproduction of uric acid can cause nephrolithiasis. These stones can be composed of uric acid or calcium phosphate. Another form of kidney disease caused by gout is uric acid nephropathy. This is a form of abacterial chronic inflammatory response with deposition of sodium urate crystals in the medullary interstitium. Acute obstructive nephropathy is relatively rare and characterized by renal failure due to uric acid precipitation in the tubules because of rapid cell lysis that occurs, for example, with chemotherapy. There is a causal interdependence between the occurrence of hyperuricemia and hypertension. Uric acid activates the renin-angiotensin-aldosterone (RAA) system and inhibits nitric oxide (NO) with the possible consequence of a rise in systemic vascular resistance or arteriolar vasculopathy; however, uric acid is also an apparently independent risk factor for atherosclerosis. In contrast to young patients, the diagnosis of an acute gout attack in the elderly can be a challenge for the physician. Polyarticular manifestations and obscure symptoms can make it difficult to differentiate it from rheumatoid arthritis and calcium pyrophosphate deposition disease (CPPD). Aspiration of synovial fluid with visualization of urate crystals using compensated polarized light microscopy is the gold standard for diagnosis of acute gout. Moreover, analysis of synovial fluid enables a distinction from septic arthritis by Gram staining and bacterial culture. Soft tissue ultrasonography is useful to detect affected synovial tissue and monosodium urate crystals within the synovial fluid. Involvement of bone occurs relatively late in the disease so that x‑ray images are not useful in the early stages but might be helpful in differential diagnostics. Dual energy computed tomography (CT) and magnetic resonance imaging (MRI) can be used for certain indications.
Literatur
1.
Zurück zum Zitat Artmann A, Ratzenbock M, Noszian I et al (2010) Dual energy CT - a new perspective in the diagnosis of gout. Rofo 182:261–266CrossRefPubMed Artmann A, Ratzenbock M, Noszian I et al (2010) Dual energy CT - a new perspective in the diagnosis of gout. Rofo 182:261–266CrossRefPubMed
2.
Zurück zum Zitat Bhansing KJ, Van Bon L, Janssen M et al (2010) Gout: A clinical syndrome illustrated and discussed. Neth J Med 68:352–359PubMed Bhansing KJ, Van Bon L, Janssen M et al (2010) Gout: A clinical syndrome illustrated and discussed. Neth J Med 68:352–359PubMed
4.
Zurück zum Zitat Crittenden DB, Pillinger MH (2011) The year in gout - 2010-2011. Bull NYU Hosp Jt Dis 69:257–263PubMed Crittenden DB, Pillinger MH (2011) The year in gout - 2010-2011. Bull NYU Hosp Jt Dis 69:257–263PubMed
5.
Zurück zum Zitat Dalbeth N, Pool B, Gamble GD et al (2010) Cellular characterization of the gouty tophus: A quantitative analysis. Arthritis Rheum 62:1549–1556CrossRefPubMed Dalbeth N, Pool B, Gamble GD et al (2010) Cellular characterization of the gouty tophus: A quantitative analysis. Arthritis Rheum 62:1549–1556CrossRefPubMed
6.
Zurück zum Zitat Dalbeth N, Stamp L (2014) Hyperuricaemia and gout: Time for a new staging system? Ann Rheum Dis 73:1598–1600CrossRefPubMed Dalbeth N, Stamp L (2014) Hyperuricaemia and gout: Time for a new staging system? Ann Rheum Dis 73:1598–1600CrossRefPubMed
7.
Zurück zum Zitat Doherty M (2009) New insights into the epidemiology of gout. Rheumatology (Oxford) 48(Suppl 2):ii2–ii8CrossRef Doherty M (2009) New insights into the epidemiology of gout. Rheumatology (Oxford) 48(Suppl 2):ii2–ii8CrossRef
8.
Zurück zum Zitat Grayson PC, Kim SY, Lavalley M et al (2011) Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:102–110CrossRef Grayson PC, Kim SY, Lavalley M et al (2011) Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:102–110CrossRef
9.
Zurück zum Zitat Harle P, Schlottmann K, Ehrenstein BP et al (2006) A patient with arthritis, severe back pain, impaired wound healing, and perforated sigmoid colon. Lancet 367:2032CrossRefPubMed Harle P, Schlottmann K, Ehrenstein BP et al (2006) A patient with arthritis, severe back pain, impaired wound healing, and perforated sigmoid colon. Lancet 367:2032CrossRefPubMed
10.
Zurück zum Zitat Hoskison KT, Wortmann RL (2007) Management of gout in older adults: Barriers to optimal control. Drugs Aging 24:21–36CrossRefPubMed Hoskison KT, Wortmann RL (2007) Management of gout in older adults: Barriers to optimal control. Drugs Aging 24:21–36CrossRefPubMed
11.
Zurück zum Zitat Masuda I, Ishikawa K (1988) Clinical features of pseudogout attack. A survey of 50 cases. Clin Orthop Relat Res 229:173–181 Masuda I, Ishikawa K (1988) Clinical features of pseudogout attack. A survey of 50 cases. Clin Orthop Relat Res 229:173–181
12.
Zurück zum Zitat Neogi T, Jansen TL, Dalbeth N et al (2015) 2015 gout classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative. Ann Rheum Dis 74:1789–1798CrossRefPubMedPubMedCentral Neogi T, Jansen TL, Dalbeth N et al (2015) 2015 gout classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative. Ann Rheum Dis 74:1789–1798CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sautin YY, Nakagawa T, Zharikov S et al (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293:C584–C596CrossRefPubMed Sautin YY, Nakagawa T, Zharikov S et al (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293:C584–C596CrossRefPubMed
16.
Zurück zum Zitat Schlesinger N, Thiele RG (2010) The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 69:1907–1912CrossRefPubMed Schlesinger N, Thiele RG (2010) The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 69:1907–1912CrossRefPubMed
18.
Zurück zum Zitat Townshend D, Pai V (2004) Gouty tenosynovitis - more common than we think? N Z Med J 117:U749PubMed Townshend D, Pai V (2004) Gouty tenosynovitis - more common than we think? N Z Med J 117:U749PubMed
19.
Zurück zum Zitat Viazzi F, Leoncini G, Pontremoli R (2011) Cardiovascular and renal effects of hyperuricaemia and gout. Reumatismo 63:253–262 Viazzi F, Leoncini G, Pontremoli R (2011) Cardiovascular and renal effects of hyperuricaemia and gout. Reumatismo 63:253–262
20.
Zurück zum Zitat Zhang W, Doherty M, Bardin T et al (2011) European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis. Ann Rheum Dis 70:563–570CrossRefPubMed Zhang W, Doherty M, Bardin T et al (2011) European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis. Ann Rheum Dis 70:563–570CrossRefPubMed
Metadaten
Titel
Crystal arthritides – gout and calcium pyrophosphate arthritis
Part 2: clinical features, diagnosis and differential diagnostics
verfasst von
Dr. med. S. Schlee
L. C. Bollheimer
T. Bertsch
C. C. Sieber
P. Härle
Publikationsdatum
23.02.2017
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 5/2018
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-017-1198-2

Weitere Artikel der Ausgabe 5/2018

Zeitschrift für Gerontologie und Geriatrie 5/2018 Zur Ausgabe

Mitteilungen des BV Geriatrie

Mitteilungen des BV Geriatrie

Mitteilungen der DGGG

Mitteilungen der DGGG